Biogen

About Biogen

Biogen is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people living with serious neurological and neurodegenerative diseases. Their mission integrates science and humanity to transform patient lives and address societal problems through purposeful and diverse scientific innovation.

Products & Services

Medicines for Neurological Diseases:Therapies targeting Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Friedreich Ataxia, Kidney Disease, Lupus, Multiple Sclerosis, Postpartum Depression, and Spinal Muscular Atrophy.

Leqembi® (lecanemab):A medicine authorized in the European Union to slow the progression of early Alzheimer’s Disease.

Specialties

Neurological Diseases Neurodegenerative Diseases Alzheimer’s Disease Amyotrophic Lateral Sclerosis (ALS) Multiple Sclerosis Spinal Muscular Atrophy Clinical Trials R&D Expertise

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Royalty Financing T: - FT: Royalty Financing	A: 250000000 MR: - FA: up to $250 million FAN: 250000000	D: 2025-02-12 FD: 2025-02-12	1 investors

Royalty Financing Latest

2025-02-12

$250.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Barry

Individual Living with Alzheimer’s Disease

P

Priya Singhal

Head of Development at Biogen

T

Teresa G. Cachero

Vice President of Asset Development and Portfolio Management and Chair of the Biogen Foundation

P

Priya Singhal, M.D., M.P.H.

Executive Vice President and Head of Development

C

Christopher A. Viehbacher

President and Chief Executive Officer

S

Susan H. Alexander

Chief Legal Officer

View 25 more team members with Pro

Unlock Full Team Directory

Recent News

Biogen Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised